Inventor
Klaus U. Weithmann
Inventor
Hofheim, DE
Overview
Patents· 34 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds20%
A61KPreparations for medical, dental or toiletry purposes18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07CAcyclic or carbocyclic compounds5%
C07JSteroids3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
A61JContainers specially adapted for medical or pharmaceutical purposes1%
C07HSugars1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
7,652,143'Cyclic ureas used as inhibitors of metalloproteases'20107,166,609'Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases'20076,933,298'Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases'20056,815,440'Cyclic and heterocyclic N-substituted -iminohydroxamic and -carboxylic acids'20046,737,246'Method for detecting protein inhibitors and ligands of medical value'20046,716,853'Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase'20046,573,277'Cyclic and heterocyclic N-substituted -iminohydroxamic and -carboxylic acids'20036,503,934'Substituted thiadiazolesulfonamides'20036,500,811'Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and use'20026,337,411'Stromelysin inhibitors'20026,235,727'Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use'20016,218,412'Substituted thiadiazolesulfonamides'20016,207,672'Cyclic and heterocyclic N-substituted .alpha.-iminohydroxamic and carboxyclic acids'20016,159,988'Arylcycloalkyl derivatives, their production and their use'20005,814,627'3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticals'19985,776,977'Arylcycloalkyl derivatives, their production and their use'19985,627,173'Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders'19975,589,514'Arylcycloalkyl derivatives, their production and their use'19965,556,870'Use of leflunomide for inhibiting interleukin 1 beta'19965,554,637'Use of leflunomide for inhibiting interleukin 1 alpha'19965,547,971'Use of leflunomide for inhibiting interleukin 8'19965,547,970'Use of leflunomide for inhibiting tumor necrosis factor alpha'19965,508,275'Lipid-selective antioxidants and their preparation and use'19965,504,084'Pharmaceutical for the treatment of skin disorders'19965,318,987'Lipid-selective antioxidants and their preparation and use'19945,137,897'2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl) thiazoles, processes for their preparation, pharmaceuticals containing them and their use'19925,043,328'Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems'19914,983,514'Method for detecting the antiaggregatory effect of vasoactive substances, specifically of inhibitors of phosphodiesterase and/or cyclooxygenase'19914,975,432'Method of using pentoxifylline for treating inflammation'19904,904,648'Pharmaceutical preparations for induction of labor and for contraceptive use'19904,880,791'Combination product composed of xanthine derivatives and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its use'19894,850,489'Dispensing packs containing pharmaceutical combinations for sequential administration'19894,694,024'Combination product composed of pyrimido-pyrimidines and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its use'19874,333,948'Pharmaceutical formulations containing prostaglandin'1982Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1982–2000Patents assigned to HOECHST AG (21)· patent assignee history
1982Based in Eppstein, DE· patent location history
1987–2010Based in Hofheim, DE· patent location history
1996Patents assigned to HOECHST ROUSSEL PHARMA (1)· patent assignee history
2001–2005Patents assigned to AVENTIS PHARMA GMBH (10)· patent assignee history
2007–2010Patents assigned to SANOFI AVENTIS DEUTSCHLAND (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOECHST AG | 21 | 1982–2000 |
| AVENTIS PHARMA GMBH | 10 | 2001–2005 |
| SANOFI AVENTIS DEUTSCHLAND | 2 | 2007–2010 |
| HOECHST ROUSSEL PHARMA | 1 | 1996 |
Locations
| Location | Patents | Span |
|---|---|---|
| Hofheim, DE | 33 | 1987–2010 |
| Eppstein, DE | 1 | 1982 |